By Kenneth Eby
Conmed Corp director and an insider Charles Farkas in the last few days paid for 292 company shares having a worth of $13,939 at the average share price of $47.7. This deal decreased his ownership of the company to 0.01% total market cap or 3,732 shares.
Conmed Corp Sentiment and Fundamentals
The seven security analysts who dissected Conmed Corp’s earnings potential, indicated an earnings per share of $1.83 and a price to earnings ratio of 25.80. They further expect Conmed Corp EPS to growth year-on-year by over 14.25%. 
Even though this insider’s acquisition is significant, Octafinance rate the stock NEUTRAL, as our well-know equities trend-following model is not giving a Buy. Conmed Corp’s stock price declined by 10.87% in the last 200 days and is still going downwards.